Physician profile
Nicholas Tran
NPI 1427670678
$3,516.90
in general payments reported to CMS, 2019-2025
12 companies · $1,063 in 2025
The $1,063 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.98 · 2022: $52.32 · 2023: $44.73 · 2024: $2,330 · 2025: $1,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,986 · Food and Beverage: $1,383 · Education: $68.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,986.40 |
| Food and Beverage | $1,382.71 |
| Education | $68.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,021.87 | 2024 | |
| Becton, Dickinson and Company | $483.63 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $317.34 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Silk Road Medical, INC. | $211.98 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Davol INC. | $193.59 | 2025 | Phasix Mesh |
| Hologic Sales and Service, LLC | $95.97 | 2024 | Trunode, Trident Specimen Radiography System |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Tela Bio, INC. | $28.36 | 2022 | |
| Medtronic, INC. | $26.98 | 2021 | |
| Innocoll Pharmaceuticals Limited | $23.96 | 2022 | |
| Atricure, INC. | $23.42 | 2023 | |
| Kci USA, INC. | $21.31 | 2023 | V.A.C. Veraflo, Activ.A.C., Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.